S. 2476
Referred to CommitteeExpanding Access to Low Cost Generic Drugs Act
Latest Action
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
2/28/2018 • Senate
Summary
Expanding Access to Low Cost Generic Drugs Act
This bill amends the Federal Food, Drug, and Cosmetic Act to disqualify from receiving market exclusivity a generic drug manufacturer who enters into an agreement with the patent holder for a brand name drug to delay getting the generic drug approved or to delay marketing it.
Introduced in Senate • 2/28/2018
Topics & Subjects
Congressional Votes (0)
No recorded votes yet
Roll call votes will appear here as the bill moves through Congress
Related Federal Spending
Sponsor & Cosponsors (1)
Sponsor
No cosponsors yet
Cosponsors may be added as the bill moves through Congress
Bill Journey
Originated in the Senate
Introduced
February 28, 2018
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Committee Review
Floor Debate
Passed Chamber
Other Chamber
President
Enacted into Law